Welcome to the website of the ERC Advanced Grant PAPA of Prof. Martin Reincke

Primary aldosteronism (PA) is nowadays widely recognised as the most frequent endocrine cause of secondary arterial hypertension.The core aim of the Pathophysiology of Primary Aldosteronism (PAPA) ERC Advanced Grant is to obtain improved insights into the humoral and molecular mechanisms underlying aldosterone excess and hypertension in PA, with a view to identifying novel therapeutic targets of potential clinical interest.

You can find all necessary information on the ongoing research, open positions and publications and browse upcoming events, i.e. conferences and seminars.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 694913.

We hope you enjoy the website and our project!